USPTO serial 79289550
RIGHTSIGN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 18, 2022
- Examiner
- TANNER, MICHAEL R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RIGHTSIGN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Hangzhou Biotest Biotech Co., Ltd.
Yuhang District; Hangzhou; 311100 Zheji, CN
Other trademarks owned by Hangzhou Biotest Biotech Co., Ltd.
Hangzhou Biotest Biotech Co., Ltd.
Yuhang District; Hangzhou; 311100 Zheji, CN
Other trademarks owned by Hangzhou Biotest Biotech Co., Ltd.
Hangzhou Biotest Biotech Co., Ltd.
Yuhang District; Hangzhou; 311100 Zheji, CN
Other trademarks owned by Hangzhou Biotest Biotech Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin O'Keefe
Kevin O'Keefe Accolade IP Limited81 70 stbrooklyn, NY 11209UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical-pharmaceutical preparations, namely, Pregnancy testing preparations, Pharmaceutical preparations for the detection and treatment of infectious diseases, Pharmaceutical preparations for the detection and treatment of cardiovascular disease, Medical diagnostic reagents and assays for testing body fluids for the presences of illicit drugs, Pharmaceutical preparations for the detection and treatment of immune system related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes for use in testing fertility levels, for testing for pregnancy, for determining progesterone production, for testing bodily fluids for the presence of infectious diseases, and for conducting diagnostic urine analysis; chemical preparations for the diagnosis of pregnancy; chemical preparations for medical purposes for diagnosing or detecting infectious diseases, early stage pregnancy, tumors, drug use, and in-vitro ovulation; chemical preparations for pharmaceutical purposes, namely, Pregnancy testing preparations, Pharmaceutical preparations for the detection and treatment of infectious diseases, Pharmaceutical preparations for the detection and treatment of cardiovascular disease, Medical diagnostic reagents and assays for testing body fluids for the presences of illicit drugs, Pharmaceutical preparations for the detection and treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; preparations of microorganisms for medical or veterinary use for use in the treatment and diagnosis of inflammation, cancer, fertility disorders, cardiovascular disease, and infectious diseases; biological preparations for medical purposes use for use in the treatment and diagnosis of inflammation, cancer, fertility disorders, cardiovascular disease, and infectious diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment and diagnosis of inflammation, cancer, fertility disorders, cardiovascular disease, and infectious diseases; diagnostic preparations for medical purposes | ACTIVE | — |
| 010 | Massage apparatus; surgical apparatus and instruments; medical apparatus and instruments being a digital polymerase chain reaction (pcr) platform comprising Flow cytometers for medical diagnostic uses for use in detecting, diagnosing and treating cancer and infectious disease and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in detecting, diagnosing and treating cancer and infectious disease; instrument cases fitted for medical instruments and for use by doctors; apparatus for use in medical analysis being a digital polymerase chain reaction (pcr) platform comprising Flow cytometers for medical diagnostic uses for use in pre-natal screenings and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in pre-natal screenings; testing apparatus for medical purposes being a digital polymerase chain reaction (dPCR) platform comprising Flow cytometers for medical diagnostic uses for testing DNA and RNA samples and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids and testing DNA and RNA samples; diagnostic apparatus for medical purposes being a digital polymerase chain reaction (dPCR) platform comprising Flow cytometers for medical diagnostic uses for use in detecting, diagnosing and treating cancer and infectious disease and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in detecting, diagnosing and treating cancer and infectious disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hangzhou Biotest Biotech Co., Ltd.
- Other trademarks owned by Hangzhou Biotest Biotech Co., Ltd.
- Other trademarks owned by Hangzhou Biotest Biotech Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named RIGHTSIGN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 27, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 27, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 18, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 18, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 10, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 22, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 22, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 14, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 14, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Nov 14, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 8, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 2, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 2, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 13, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 13, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 13, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 29, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 18, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 18, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 18, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 18, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 15, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 9, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 9, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 9, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2021 | ALIE | ASSIGNED TO LIE | — |
| Mar 18, 2021 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Mar 17, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 17, 2021 | PETG | PETITION TO REVIVE-GRANTED | — |
| Mar 17, 2021 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Mar 17, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 17, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 17, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 17, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 17, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 5, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 12, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 21, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 16, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |